Pr Dre Brigitte Jolles-Haeberli

Hôpital orthopédique
HO 03
1011 Lausanne

Tel. +41 21 314 9791
Fax +41 21 314 9792


Prof. Jolles-Haeberli received a Microtechnology Engineering Degree (MSc) with honours from the Ecole Polytechnique Fédérale de Lauasanne (EPFL) in 1990. Five years later, she obtained the Swiss Federal Diploma of Medicine (MD) and defended her Doctoral thesis in Medicine with honours at the University of Lausanne (UNIL). In 2002, she graduated in Clinical Epidemiology and successfully completed a Clinical Fellowship in Arthritis Surgery at the University of Toronto. Thereafter, she obtained the Swiss Federal Diploma of Specialist in Orthopaedic Surgery and Traumatology and lead the hip and knee arthroplasty team at the Lausanne University Hospital (CHUV) until the end of 2013.

She is Professor at UNIL (Assistant Professor (PD) since 2005 and Associate Professor since 2010) and at EPFL (Adjunct Professor since 2008). Between 2008 and 2014 she was the head of the Interinstitutional Center of Translational Biomechanics (CHUV-UNIL-EPFL). In 2014, she founded the Swiss BioMotion Laboratory (SBML) with Dr Julien Favre, and co-leads this research Lab since then with him.

In parallel to her research activities, she is currently senior consultant orthopaedic surgeon in hip and knee surgery at the Hirslanden clinics in Lausanne and the operational director of the Department of Musculoskeletal Medicine (DAL) at CHUV.


Prof. Jolles-Haeberli research combines medical knowledge and biomedical engineering knowhow with the aim of promoting the transfer of fundamental findings in science laboratory settings to clinical applications. She is particularly active in the characterization of human mobility and locomotion in daily conditions in order to provide objective clinical metrics for diagnosis and outcome evaluation of treatments as well as useful parameters to increase sport performances. Currently, her research primarily focuses on hip and knee injuries and osteoarthritis, particularly on conservative and surgical solutions to improve patient conditions.

 Dernière mise à jour le 01/09/2022 à 15:37